Cognios Beta Neutral Large Cap Fund, LP Organon & Co. Transaction History

Cognios Beta Neutral Large Cap Fund, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$16.59 - $23.77 $1,128 - $1,616	68 Added 0.23%	29,321 $509,000
Q2 2023 Aug 03, 2023	SELL	$19.27 - $24.63 $90,202 - $115,293	-4,681 Reduced 13.79%	29,253 $608,000
Q1 2023 May 02, 2023	SELL	$21.42 - $32.08 $6,575 - $9,848	-307 Reduced 0.9%	33,934 $798,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $798,157 - $979,635	34,241 New	34,241 $956 Million

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.